☆ 4.7 Review

Role of Angiotensin II in Cardiovascular Diseases: Introducing Bisartans as a Novel Therapy for Coronavirus 2019

BIOMOLECULES (2023)

Related references

Note: Only part of the references are listed.
Article Virology

Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity

Harry Ridgway et al.

Summary: This study reported the variant distribution of SARS-CoV-2 across EU/EEA countries and investigated the driving forces behind mutations that trigger infections. Computational approaches were used to examine the stabilizing effects of key mutations on the RBD-ACE2 complex in Alpha, Beta, Gamma, Delta, Epsilon, Kappa, Lambda, and Omicron variants. Critical mutations found in the delta variant and two omicron variants were identified, which may contribute to increased transmissibility and morbidity.

VIRUSES-BASEL (2023)

Add to Collection
Letter Virology

Hypertension is still a moving target in the context of COVID-19 and post-acute COVID-19 syndrome

Mohnad Abdalla et al.

JOURNAL OF MEDICAL VIROLOGY (2023)

Add to Collection
Article Cardiac & Cardiovascular Systems

Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association

Connie W. Tsao et al.

Summary: This article introduces the latest statistics on heart disease, stroke, and cardiovascular risk factors published by the American Heart Association in conjunction with the National Institutes of Health. The Statistical Update includes data on a range of clinical heart and circulatory disease conditions and their associated outcomes. It serves as a critical resource for the general public, policymakers, healthcare professionals, researchers, and others seeking the best available data.

CIRCULATION (2022)

Add to Collection
Review Immunology

A global picture: therapeutic perspectives for COVID-19

Vivek P. Chavda et al.

Summary: This article provides a comprehensive overview of SARS-CoV-2 and COVID-19, including viral transmission and subsequent events in the human body. It also presents different drugs and vaccines used for the management of COVID-19. Several natural drugs are proposed for COVID-19 management, and an overview of post-COVID-19 complications in recovered patients is also provided.

IMMUNOTHERAPY (2022)

Add to Collection
Review Immunology

The T cell immune response against SARS-CoV-2

Paul Moss

Summary: T cell immunity plays a central role in controlling SARS-CoV-2 infection, with early responses correlating with protection. T cell memory provides broad recognition of viral proteins, limiting the impact of viral variants and offering protection against severe disease. Current COVID-19 vaccines elicit robust T cell responses, contributing to the prevention of hospitalization or death. Therefore, the importance of T cell immunity may have been underestimated.

NATURE IMMUNOLOGY (2022)

Add to Collection
Review Biology

The Impact of COVID-19 On Comorbidities: A Review Of Recent Updates For Combating It

Jonaid Ahmad Malik et al.

Summary: This study focuses on the impact of COVID-19 on pre-existing comorbidities such as CVDs, NDs, COPD, highlighting that 75% of hospitalized COVID-19 patients have comorbidities. Common comorbidities include hypertension, NDs, diabetes, cancer, with older and polypharmacy patients at higher risk for COVID-19 complications.

SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2022)

Add to Collection
Review Biochemistry & Molecular Biology

The Role of Nuclear Factor Kappa B (NF-κB) in Development and Treatment of COVID-19: Review

Monika Gudowska-Sawczuk et al.

Summary: This review paper focuses on the role of Nuclear Factor kappa B (NF-kappa B) in the development of COVID-19 and its potential application in the treatment of SARS-CoV-2 infection. It highlights the important functions of NF-kappa B in modulating the inflammatory response and the increased activation of NF-kappa B in SARS-CoV-2 infection. The modulation of NF-kappa B can result in decreased synthesis of proinflammatory factors caused by SARS-CoV-2 infection.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection
Article Biochemistry & Molecular Biology

Angiotensin II Promotes SARS-CoV-2 Infection via Upregulation of ACE2 in Human Bronchial Cells

Ilaria Caputo et al.

Summary: Blockers of the renin-angiotensin system (RAS) can increase the expression of ACE2, the cellular receptor of SARS-CoV-2, and thus increase the risk of COVID-19. This study found that angiotensin II (Ang II) significantly increased the levels of ACE2 expression by acting on the angiotensin type 1 receptor, resulting in enhanced viral entry into cells. However, the blockade of ACE-1-mediated Ang II formation and ACE2-mediated Ang II conversion did not have any effect. Therefore, increased production of Ang II in patients with an activated RAS may lead to a greater spread of COVID-19 infection in lung cells.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection
Review Health Care Sciences & Services

The divergent protective effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on clinical outcomes of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis

Qiuping Xie et al.

Summary: This meta-analysis found that treatment with ACEIs or ARBs does not worsen clinical outcomes in COVID-19 patients, and may actually reduce the risk of severe/death outcomes, especially in Asia. Therefore, discontinuation of ACEI or ARB therapy during COVID-19 infection is not recommended.

ANNALS OF PALLIATIVE MEDICINE (2022)

Add to Collection
Article Biochemistry & Molecular Biology

Angiotensin II Exaggerates SARS-CoV-2 Specific T-Cell Response in Convalescent Individuals following COVID-19

Moudhi Almutlaq et al.

Summary: This study demonstrates that angiotensin II (Ang II) exacerbates the T-cell response to SARS-CoV-2 in recovered COVID-19 patients. The presence of Ang II increases the phosphorylation levels of proteins involved in cardiovascular diseases, inflammation, and viral infection. These findings suggest that Ang II may worsen the inflammatory response and alter the immune response to a more inflammatory profile against SARS-CoV-2 infection.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection
Article Biochemistry & Molecular Biology

Actions of Novel Angiotensin Receptor Blocking Drugs, Bisartans, Relevant for COVID-19 Therapy: Biased Agonism at Angiotensin Receptors and the Beneficial Effects of Neprilysin in the Renin Angiotensin System

Graham J. Moore et al.

Summary: Angiotensin receptor blockers (ARBs) have shown inverse agonist effects in the treatment of hypertension and potential SARS-CoV-2 infection. A peptide encoded by mRNA complementary to ANG II itself has been identified, which acts as an inverse agonist. The switch between activated and inverse agonist states at the angiotensin AR1 receptor can be explained by the formation of the ANG II charge-relay system. In addition, a new class of anionic biphenyl-tetrazole sartans, known as "Bisartans," has been found to inhibit ANG II-induced pulmonary edema and ACE2-mediated viral entry to cells.

MOLECULES (2022)

Add to Collection
Article Public, Environmental & Occupational Health

Bibliometric and visual analysis of cardiovascular diseases and COVID-19 research

Namin Wei et al.

Summary: This study conducted a bibliometric and visual analysis of the published relationship between cardiovascular diseases (CVDs) and COVID-19, revealing a wide range of research interests in specific diseases, pathogenesis, therapeutic drugs, and clinical characteristics.

FRONTIERS IN PUBLIC HEALTH (2022)

Add to Collection
Article Biochemistry & Molecular Biology

Diminazene Aceturate Reduces Angiotensin II Constriction and Interacts with the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2

John M. Matsoukas et al.

Summary: Diminazene aceturate (DIZE) is a potential angiotensin-converting enzyme 2 (ACE2) activator and angiotensin type 1 receptor antagonist (AT(1)R). It converts toxic angiotensin II (AngII) to vasodilatory peptides and shows promise as a treatment for COVID-19.

BIOMEDICINES (2022)

Add to Collection
Review Biochemistry & Molecular Biology

Pathophysiology of Cardiovascular Diseases: New Insights into Molecular Mechanisms of Atherosclerosis, Arterial Hypertension, and Coronary Artery Disease

Weronika Frak et al.

Summary: Cardiovascular diseases (CVDs) are disorders associated with the heart and circulatory system, with atherosclerosis as its underlying cause. CVDs are the leading cause of morbidity and mortality globally, creating a significant public health concern. This review summarizes the pathophysiological implications of CVDs, focusing on coronary artery disease and atherosclerosis. Inflammatory factors and genetic risk factors have been identified in association with CVDs.

BIOMEDICINES (2022)

Add to Collection
Article Cardiac & Cardiovascular Systems

Plasma Angiotensin II Is Increased in Critical Coronavirus Disease 2019

Rafael L. Camargo et al.

Summary: This study investigated the blood levels of ACE, ACE2, angiotensin-II, angiotensin (1-7), and angiotensin (1-9) in patients with COVID-19 and found that elevated levels of angiotensin-II were associated with a higher risk of developing critical symptoms. Early measurement of angiotensin-II could serve as a useful biomarker for identifying patients at higher risk of severe progression of the disease.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Add to Collection
Article Biology

Alamandine alleviated heart failure and fibrosis in myocardial infarction mice

Kun Zhao et al.

Summary: Alamandine can alleviate cardiac dysfunction and attenuate cardiac fibrosis by inhibiting oxidative stress.

BIOLOGY DIRECT (2022)

Add to Collection
Article Pharmacology & Pharmacy

Losartan attenuates sepsis-induced cardiomyopathy by regulating macrophage polarization via TLR4-mediated NF-κB and MAPK signaling

Xin-Sen Chen et al.

Summary: This study investigated the association between the Ang II/AT1R axis and sepsis-induced cardiomyopathy (SIC) and found that the AT1R blocker losartan can reduce myocardial injury in SIC.

PHARMACOLOGICAL RESEARCH (2022)

Add to Collection
Letter Cell Biology

Potential of angiotensin II receptor blocker telmisartan in reducing mortality among hospitalized patients with COVID-19 compared with recommended drugs

Dengyuan Liu et al.

CELL DISCOVERY (2022)

Add to Collection
Article Biochemistry & Molecular Biology

Discovery of a new generation of angiotensin receptor blocking drugs: Receptor mechanisms and in silico binding to enzymes relevant to SARS-CoV-2

Harry Ridgway et al.

Summary: The discovery of a new class of arterial antihypertensive drugs called bisartans is reported, which may have potential benefits in treating various diseases including heart disease, diabetes, renal dysfunction, and possibly COVID-19. Molecular modeling studies suggest that bisartans have strong binding affinities for ACE2/spike protein complex and may inhibit viral entry into host cells.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2022)

Add to Collection
Article Cardiac & Cardiovascular Systems

Renin Angiotensin System Blockers and Risk of Mortality in Hypertensive Patients Hospitalized for COVID-19: An Italian Registry

Fabio Angeli et al.

Summary: This prospective study indicates that exposure to renin-angiotensin system modifiers, particularly angiotensin receptor blockers (ARBs), significantly reduces the risk of in-hospital mortality in patients with COVID-19.

JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE (2022)

Add to Collection
Review Emergency Medicine

Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis

Amirhossein Hessami et al.

Summary: A systematic review and meta-analysis revealed a high burden of cardiovascular diseases among COVID-19 patients, significantly associated with mortality and ICU admission. Proper monitoring and management of cardiovascular conditions in COVID-19 patients are highly recommended to prevent critical outcomes.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2021)

Add to Collection
Article Cardiac & Cardiovascular Systems

Association of ACEi/ARB Use and Clinical Outcomes of COVID-19 Patients With Hypertension

Jing Ma et al.

Summary: The study found that among COVID-19 patients with preexisting hypertension in non-endemic areas, the use of ACEi/ARB was not associated with an increased risk of disease severity compared to patients not using ACEi/ARB. Adjusted analysis showed that the use of ACEi/ARB reduced the probability of endpoint events, indicating a potential benefit in COVID-19 treatment.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Add to Collection
Letter Infectious Diseases

Estimating clinical SARS-CoV-2 infectiousness in Vero E6 and primary airway epithelial cells

Manel Essaidi-Laziosi et al.

LANCET MICROBE (2021)

Add to Collection
Article Biochemistry & Molecular Biology

A model for COVID-19-induced dysregulation of ACE2 shedding by ADAM17

Eamonn F. Healy et al.

Summary: The ACE2 receptor plays a crucial role in the cardiovascular system and is the key point of contact for the coronavirus spike protein. The shedding of ACE2 by ADAM17 and cleavage by TMPRSS2 are essential for virus entry into cells, with inflammation potentially impacting this process.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)

Add to Collection
Review Biochemistry & Molecular Biology

Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?

Laura Kate Gadanec et al.

Summary: The S protein of SARS-CoV-2 may exploit multiple receptors for infection and interact with both immune and non-immune cells through C-lectin type receptors (CLR), toll-like receptors (TLR), neuropilin-1 (NRP1), and glucose regulated protein 78 (GRP78), potentially driving severe immunopathological inflammation and facilitating systemic spread of infection. Targeting these receptors, as well as other receptors such as Toll-like receptors (TLRs), CLR, Ezrin, and dipeptidyl peptidase-4, could provide therapeutic targets against COVID-19 by enhancing anti-viral immunity and viral clearance.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection
Editorial Material Peripheral Vascular Disease

Is hypertension without any other comorbidities an independent predictor for COVID-19 severity and mortality?

Martin R. Salazar

JOURNAL OF CLINICAL HYPERTENSION (2021)

Add to Collection
Review Cell Biology

Neutrophils mediate Th17 promotion in COVID-19 patients

Zuzana Parackova et al.

Summary: Neutrophils play a crucial role in the pathophysiology of COVID-19 by affecting the polarization of T cells, leading to a skewed Th1/Th17 adaptive immune response. Targeting neutrophils and Th17 may represent a potential therapeutic strategy for severe COVID-19 patients.

JOURNAL OF LEUKOCYTE BIOLOGY (2021)

Add to Collection
Review Biochemistry & Molecular Biology

From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy

John Matsoukas et al.

Summary: Angiotensin II is a widely studied hormone that has led to the design and synthesis of non-peptide drugs. These drugs have made breakthroughs in the treatment of hypertension and were widely marketed in the 1990s. Recent studies have found that RAS inhibitors can help resist SARS-CoV-2 infection, maintain homeostasis, and vasodilation.

MOLECULES (2021)

Add to Collection
Article Public, Environmental & Occupational Health

Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017

Maedeh Amini et al.

Summary: The study found a global upward trend in the incidence of cardiovascular diseases (CVDs) until 1996, followed by a downward trend. Nearly all countries experienced a significant decline in mortality rates from 1990 to 2017. Developed countries saw a faster reduction in incidence and mortality rates compared to developing countries, while the global MIR had a slight decrease with developing nations showing a more gradual decline.

BMC PUBLIC HEALTH (2021)

Add to Collection
Article Pharmacology & Pharmacy

Alamandine via MrgD receptor attenuates pulmonary fibrosis via NOX4 and autophagy pathway

Qingxia Liu et al.

Summary: ALA reduces oxidative injury and induces autophagy through the MrgD receptor, alleviating pulmonary fibrosis.

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2021)

Add to Collection
Editorial Material Microbiology

Dual targeting of toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment

Laura Kate Gadanec et al.

FUTURE MICROBIOLOGY (2021)

Add to Collection
Article Multidisciplinary Sciences

Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease

Sebastian Cremer et al.

Summary: Patients with cardiovascular comorbidities who take angiotensin II receptor blockers have lower mortality rates in COVID-19 compared to those who do not take these medications. This effect is particularly significant in patients who present early in the course of the disease. Additionally, these patients on ARBs also show lower levels of inflammatory markers and reduced frequency of reaching mortality-predicting thresholds.

PLOS ONE (2021)

Add to Collection
Article Immunology

Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia

Andre Santa Cruz et al.

Summary: Hyper-inflammatory responses induced by SARS-CoV-2 are major factors in disease severity and death, with IL-6 levels showing a significant correlation with disease stages and outcomes in COVID-19 patients, particularly in relation to respiratory failure. IL-6 also outperforms CRP as a predictive marker for disease progression.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection
Review Cardiac & Cardiovascular Systems

COVID-19 and the Heart: A Systematic Review of Cardiac Autopsies

Ashraf Roshdy et al.

Summary: Analysis of cardiac tissue autopsy findings in COVID-19 decedents revealed common cardiac pathologies such as cardiac dilation, ischemia, and myocarditis. A minority of cases showed infiltration of SARS-CoV-2 into the myocardium. Standardization of cardiac postmortem protocols is needed for further research.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Add to Collection
Review Medicine, Research & Experimental

Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severity

Maryam Eskandari Mehrabadi et al.

Summary: This article discusses the impact of the novel coronavirus on ACE2 substrates and products, pointing out that this imbalance exacerbates the severity of COVID-19. It proposes multiple therapeutic strategies to rebalance ACE2 products and alleviate the symptoms of the disease.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Add to Collection
Review Cardiac & Cardiovascular Systems

COVID-19 and Cardiovascular Disease From Bench to Bedside

Mina K. Chung et al.

Summary: COVID-19, caused by SARS-CoV-2, has potential consequences on the cardiovascular health of millions of survivors worldwide. The virus can infect the heart, vascular tissues, and circulating cells through ACE2, leading to acute cardiac injury. This update reviews clinical manifestations, impact mechanisms, and management implications for patients after recovering from acute COVID-19 infection.

CIRCULATION RESEARCH (2021)

Add to Collection
Article Toxicology

Alamandine significantly reduces doxorubicin-induced cardiotoxicity in rats

Ava Soltani Hekmat et al.

Summary: Alamandine co-therapy can prevent DOX-induced cardiotoxicity by enhancing endogenous antioxidants and anti-inflammatory effects, resulting in reduced oxidative stress, inflammatory cytokines, and apoptosis in rat models.

HUMAN & EXPERIMENTAL TOXICOLOGY (2021)

Add to Collection
Editorial Material Pharmacology & Pharmacy

Angiotensin Receptor Blockers for COVID-19: Pathophysiological and Pharmacological Considerations About Ongoing and Future Prospective Clinical Trials

Rodolfo Pedro Rothlin et al.

Summary: The COVID-19 pandemic necessitates a quick response to find therapeutic tools that can effectively reduce morbidity and mortality. Inhibition of the renin-angiotensin system is being explored as a potential pathway to alleviate lung inflammation driven by angiotensin II, leading to the initiation of prospective clinical trials. The interpretation of these trials' results will depend on the stage and severity of the disease, as well as the timing and dosage of the prescribed medications in relation to the diagnosis of COVID-19.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection
Review Physiology

COVID-19 and Hypertension: The What, the Why, and the How

Shah-Abas Muhamad et al.

Summary: Observational studies globally have shown that most COVID-19 patients have preexisting hypertension, raising questions about the potential relationship between COVID-19 and hypertension. This review summarizes the current understanding of the link between hypertension and COVID-19, as well as its underlying mechanisms.

FRONTIERS IN PHYSIOLOGY (2021)

Add to Collection
Review Immunology

The Role of Macrophages in the Pathogenesis of SARS-CoV-2-Associated Acute Respiratory Distress Syndrome

Anna Kosyreva et al.

Summary: Macrophages play a crucial role in COVID-19, especially in cases complicated by ARDS. Macrophage activation syndrome is predominantly caused by massive activation of macrophages. Reprogrammed macrophages with stable pro- or anti-inflammatory phenotypes may have potential utility in the treatment of ARDS.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection
Article Infectious Diseases

Candesartan as a tentative treatment for COVID-19: A prospective non-randomized open-label study

Antonia Anna Lukito et al.

Summary: This study investigated the impact of adding candesartan to the standard care regimen on COVID-19 patients. The results showed that candesartan significantly reduced hospital stay length and improved outcomes in non-obese patients, without increasing the risk of intensive care.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection
Article Immunology

Angiotensin II Receptor Blockers (ARBs Antihypertensive Agents) Increase Replication of SARS-CoV-2 in Vero E6 Cells

Gabriel Augusto Pires de Souza et al.

Summary: The study found that ARBs may increase ACE2 expression, promoting SARS-CoV-2 replication in cells and increasing viral production. As a result, the use of ARBs in hypertensive patients infected with SARS-CoV-2 should be carefully evaluated.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Add to Collection
Review Pharmacology & Pharmacy

The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19

M. Ekholm et al.

Summary: Atherosclerosis is a disease caused by chronic inflammation and endothelial dysfunction, with up-regulated mediators of inflammation in affected individuals. Oxidative stress, imbalance between antioxidants and oxidants, leads to tissue damage. The renin-angiotensin-aldosterone system plays a vital role in vascular disease pathobiology, with angiotensin II causing hypertension and reactive oxygen species production. Blocking this system could potentially reduce inflammatory and thrombotic complications.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection
Review Pharmacology & Pharmacy

An Insight on Multicentric Signaling of Angiotensin II in Cardiovascular system: A Recent Update

Kanika Verma et al.

Summary: The multifaceted nature of the renin-angiotensin system allows it to play various roles in the pathogenesis of cardiovascular diseases. Angiotensin II within the RAS family has diverse potential effects and the AT(1)R receptor is known to mediate the majority of its functions, with crosstalk between its signaling cascades and other pathways being recognized. Recent research focuses on understanding Ang II receptor signal transduction and the functional significance in the cardiovascular system for potential therapeutic applications, as well as exploring the role of stem cell-based therapies in cardiovascular health.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection
Article Pharmacology & Pharmacy

Protective effect of alamandine on doxorubicin-induced nephrotoxicity in rats

Ava Soltani Hekmat et al.

Summary: This study demonstrated that alamandine can protect against doxorubicin-induced nephrotoxicity in rats by reducing pro-inflammatory cytokines and pro-fibrotic proteins levels, as well as preserving renal function.

BMC PHARMACOLOGY & TOXICOLOGY (2021)

Add to Collection
Article Immunology

Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients

Ikram Omar Osman et al.

Summary: SARS-CoV-2 infection can lead to variations in ACE2 expression and Ang II plasma concentration, potentially affecting blood pressure regulation and COVID-19 outcomes.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection
Review Medicine, General & Internal

ACE2, the Counter-Regulatory Renin-Angiotensin System Axis and COVID-19 Severity

Filippos Triposkiadis et al.

Summary: ACE2 acts as the entry receptor for SARS-CoV-2 and can convert harmful substances to protective ones, suggesting that upregulation of ACE2 may be beneficial in mitigating COVID-19 risks. Limited involvement of ACE2 in the lung counter-regulatory RAS axis, increasing ACE2 expression may predispose to more severe disease, particularly in the presence of relevant risk factors.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection
Article Biochemistry & Molecular Biology

Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers-Relevance to COVID-19

Graham J. Moore et al.

Summary: The study explores the charge relay system in Angiotensin II and its activation mechanism involving different amino acids, as well as how recent crystallography studies have shed light on angiotensin receptor blockers. The research also demonstrates the protective effects of ARBs in hypertensive patients infected with SARS-CoV-2 and proposes the potential of using ARBs to target and prevent cytokine storms in the disease.

BIOMOLECULES (2021)

Add to Collection
Article Peripheral Vascular Disease

Assessment of Alamandine in Pulmonary Fibrosis and Respiratory Mechanics in Rodents

Renata Streck Fernandes et al.

Summary: Treatment with ALA can attenuate the progression of PF, improve respiratory system mechanics, and maintain weight gain in fibrotic animals.

JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2021)

Add to Collection
Article Biochemistry & Molecular Biology

Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks

Louisa Ruhl et al.

Summary: The study investigated the immune response in severe COVID-19 patients during acute phase and in convalescent patients, revealing a highly inflammatory microenvironment and endothelial injury in severe cases.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Add to Collection
Article Medicine, General & Internal

Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial

Mariano Duarte et al.

Summary: This study in Argentina investigated the potential treatment of Covid19-induced lung inflammation using telmisartan. Results showed that patients treated with telmisartan had better CRP levels and shorter time to discharge compared to standard care alone.

ECLINICALMEDICINE (2021)

Add to Collection
Review Cardiac & Cardiovascular Systems

Counter-regulatory renin-angiotensin system in cardiovascular disease

Maria Paz Ocaranza et al.

NATURE REVIEWS CARDIOLOGY (2020)

Add to Collection
Editorial Material Chemistry, Medicinal

Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics

David Gurwitz

DRUG DEVELOPMENT RESEARCH (2020)

Add to Collection
Article Biology

Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury

Yingxia Liu et al.

SCIENCE CHINA-LIFE SCIENCES (2020)

Add to Collection
Article Cardiac & Cardiovascular Systems

Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19

Peng Zhang et al.

CIRCULATION RESEARCH (2020)

Add to Collection
Review Rheumatology

Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment

Mehmet Soy et al.

CLINICAL RHEUMATOLOGY (2020)

Add to Collection
Article Chemistry, Medicinal

Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID-19

Rodolfo Pedro Rothlin et al.

DRUG DEVELOPMENT RESEARCH (2020)

Add to Collection
Review Cardiac & Cardiovascular Systems

Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB

Juan Simon Rico-Mesa et al.

CURRENT CARDIOLOGY REPORTS (2020)

Add to Collection
Article Medicine, General & Internal

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Maximilian Ackermann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection
Article Chemistry, Multidisciplinary

Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication

Xiaocong Pang et al.

ACTA PHARMACOLOGICA SINICA (2020)

Add to Collection
Review Immunology

COVID-19 pathophysiology: A review

Koichi Yuki et al.

CLINICAL IMMUNOLOGY (2020)

Add to Collection
Editorial Material Respiratory System

Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?

Alice Huertas et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

Add to Collection
Article Cardiac & Cardiovascular Systems

Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people

Julia Hippisley-Cox et al.

HEART (2020)

Add to Collection
Review Infectious Diseases

Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases

Giovanni A. Rossi et al.

INFECTION (2020)

Add to Collection
Review Biochemistry & Molecular Biology

Angiotensin II, Hypercholesterolemia, and Vascular Smooth Muscle Cells: A Perfect Trio for Vascular Pathology

Amanda St Paul et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection
Review Immunology

The COVID-19 Cytokine Storm; What We Know So Far

Dina Ragab et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection
Article Virology

Prognostic value of interleukin-6, C -reactive protein, patients with COVID-19 and procalcitonin in

Fang Liu et al.

JOURNAL OF CLINICAL VIROLOGY (2020)

Add to Collection
Article Peripheral Vascular Disease

Effects of Angiotensin Receptor Blockers (ARBs) on In-Hospital Outcomes of Patients With Hypertension and Confirmed or Clinically Suspected COVID-19

Abbas Soleimani et al.

AMERICAN JOURNAL OF HYPERTENSION (2020)

Add to Collection
Editorial Material Urology & Nephrology

Blockade of SARS-CoV-2 infection by recombinant soluble ACE2

Francois Alhenc-Gelas et al.

KIDNEY INTERNATIONAL (2020)

Add to Collection
Editorial Material Geriatrics & Gerontology

Could DIZE be the answer to COVID-19?

Tawar Qaradakhi et al.

MATURITAS (2020)

Add to Collection
Article Geriatrics & Gerontology

COVID-19 In-Hospital Mortality and Use of Renin-Angiotensin System Blockers in Geriatrics Patients

Bastien Genet et al.

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2020)

Add to Collection
Article Multidisciplinary Sciences

Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor

Jinsung Yang et al.

NATURE COMMUNICATIONS (2020)

Add to Collection
Article Cardiac & Cardiovascular Systems

Antecedent Administration of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for COVID-19 Syndrome

Alberto Palazzuoli et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)

Add to Collection
Review Immunology

T Cells in Autoimmunity-Associated Cardiovascular Diseases

Daniella Muallem Schwartz et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection
Review Cell Biology

Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System

Larissa Braga Costa et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Add to Collection
Review Biochemistry & Molecular Biology

Oxidative Stress in Cardiovascular Diseases

Emilie Dubois-Deruy et al.

ANTIOXIDANTS (2020)

Add to Collection
Review Cardiac & Cardiovascular Systems

Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019 Update From the GBD 2019 Study

Gregory A. Roth et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Add to Collection
Article Microbiology

SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells

Tapas Patra et al.

PLOS PATHOGENS (2020)

Add to Collection
Article Pharmacology & Pharmacy

Signal Transduction Profiling of Angiotensin II Type 1 Receptor With Mutations Associated to Atrial Fibrillation in Humans

Sarah C. Simoes et al.

FRONTIERS IN PHARMACOLOGY (2020)

Add to Collection
Article Biochemistry & Molecular Biology

Novel Therapeutic Effects of Pterosin B on Ang II-Induced Cardiomyocyte Hypertrophy

Chang Youn Lee et al.

MOLECULES (2020)

Add to Collection
Article Medicine, Research & Experimental

Candesartan could ameliorate the COVID-19 cytokine storm

Abdel G. Elkahloun et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Add to Collection
Review Cardiac & Cardiovascular Systems

Inflammation and cardiovascular disease: From mechanisms to therapeutics

Abdulhamied Alfaddagh et al.

AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)

Add to Collection
Review Medicine, General & Internal

Inflammatory cytokines in the pathogenesis of cardiovascular disease and cancer

Mohammad Nurul Amin et al.

SAGE OPEN MEDICINE (2020)

Add to Collection
Letter Critical Care Medicine

Angiotensin II infusion in COVID-19-associated vasodilatory shock: a case series

Alberto Zangrillo et al.

CRITICAL CARE (2020)

Add to Collection
Letter Critical Care Medicine

Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients

Zhiyong Wu et al.

CRITICAL CARE (2020)

Add to Collection
Review Immunology

How COVID-19 induces cytokine storm with high mortality

Shintaro Hojyo et al.

INFLAMMATION AND REGENERATION (2020)

Add to Collection
Article Immunology

Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension

Juan Meng et al.

EMERGING MICROBES & INFECTIONS (2020)

Add to Collection
Article Medicine, Research & Experimental

Alamandine attenuates arterial remodelling induced by transverse aortic constriction in mice

Fernando Pedro de Souza-Neto et al.

CLINICAL SCIENCE (2019)

Add to Collection
Article Multidisciplinary Sciences

Circulating angiotensin peptides levels in Acute Respiratory Distress Syndrome correlate with clinical outcomes: A pilot study

Raju Reddy et al.

PLOS ONE (2019)

Add to Collection
Article Critical Care Medicine

Classic and Nonclassic Renin-Angiotensin Systems in the Critically Ill

Laurent Bitker et al.

CRITICAL CARE CLINICS (2019)

Add to Collection
Review Nutrition & Dietetics

Oxidative Stress in Cardiovascular Diseases: Still a Therapeutic Target?

Thomas Senoner et al.

NUTRIENTS (2019)

Add to Collection
Article Cardiac & Cardiovascular Systems

Genetic deletion of the alamandine receptor MRGD leads to dilated cardiomyopathy in mice

Aline Cristina Oliveira et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2019)

Add to Collection
Article Multidisciplinary Sciences

Occurrence of the potent mutagens 2-nitrobenzanthrone and 3-nitrobenzanthrone in fine airborne particles

Aldenor G. Santos et al.

SCIENTIFIC REPORTS (2019)

Add to Collection
Article Biochemistry & Molecular Biology

Endothelial dysfunction induces atherosclerosis: increased aggrecan expression promotes apoptosis in vascular smooth muscle cells

Sang-Min Kim et al.

BMB REPORTS (2019)

Add to Collection
Review Immunology

Overview of the IL-1 family in innate inflammation and acquired immunity

Charles A. Dinarello

IMMUNOLOGICAL REVIEWS (2018)

Add to Collection
Review Pharmacology & Pharmacy

The Conducted Vasomotor Response: Function, Biophysical Basis, and Pharmacological Control

Donald G. Welsh et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58 (2018)

Add to Collection
Editorial Material Hematology

Renin-Angiotensin System and Cardiovascular Functions

Chia-Hua Wu et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)

Add to Collection
Review Cardiac & Cardiovascular Systems

Vascular smooth muscle contraction in hypertension

Rhian M. Touyz et al.

CARDIOVASCULAR RESEARCH (2018)

Add to Collection
Review Peripheral Vascular Disease

Dysregulation of the Renin-Angiotensin System and the Vasopressinergic System Interactions in Cardiovascular Disorders

Ewa Szczepanska-Sadowska et al.

CURRENT HYPERTENSION REPORTS (2018)

Add to Collection
Article Pharmacology & Pharmacy

Targeting the renin-angiotensin system as novel therapeutic strategy for pulmonary diseases

Wan Shun Daniel Tan et al.

CURRENT OPINION IN PHARMACOLOGY (2018)

Add to Collection
Review Physiology

ANGIOTENSIN II SIGNAL TRANSDUCTION: AN UPDATE ON MECHANISMS OF PHYSIOLOGY AND PATHOPHYSIOLOGY

Steven J. Forrester et al.

PHYSIOLOGICAL REVIEWS (2018)

Add to Collection
Article Peripheral Vascular Disease

Angiotensin IV suppresses inflammation in the brains of rats with chronic cerebral hypoperfusion

Qing-Guang Wang et al.

JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2018)

Add to Collection
Review Physiology

Vascular Oxidative Stress: Impact and Therapeutic Approaches

Cristina M. Sena et al.

FRONTIERS IN PHYSIOLOGY (2018)

Add to Collection
Article Peripheral Vascular Disease

Involvement of vascular peroxidase 1 in angiotensin II-induced hypertrophy of H9c2 cells

Wei Yang et al.

JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2017)

Add to Collection
Review Pharmacology & Pharmacy

Current topics in angiotensin II type 1 receptor research: Focus on inverse agonism, receptor dimerization and biased agonism

Takanobu Takezako et al.

PHARMACOLOGICAL RESEARCH (2017)

Add to Collection
Review Pharmacology & Pharmacy

AT1 receptor signaling pathways in the cardiovascular system

Tatsuo Kawai et al.

PHARMACOLOGICAL RESEARCH (2017)

Add to Collection
Article Genetics & Heredity

Angiotensin-converting enzyme 2 inhibits high-mobility group box 1 and attenuates cardiac dysfunction post-myocardial ischemia

Yan Fei Qi et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2016)

Add to Collection
Article Cardiac & Cardiovascular Systems

Context-dependent effects of SOCS3 in angiotensin II-induced vascular dysfunction and hypertension in mice: mechanisms and role of bone marrow-derived cells

Ying Li et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2016)

Add to Collection
Article Peripheral Vascular Disease

Activation of Human T Cells in Hypertension Studies of Humanized Mice and Hypertensive Humans

Hana A. Itani et al.

HYPERTENSION (2016)

Add to Collection
Review Urology & Nephrology

TGF-β: the master regulator of fibrosis

Xiao-ming Meng et al.

NATURE REVIEWS NEPHROLOGY (2016)

Add to Collection
Review Pharmacology & Pharmacy

Angiotensin (1-7) and Alamandine: Similarities and differences

Tawar Qaradakhi et al.

PHARMACOLOGICAL RESEARCH (2016)

Add to Collection
Article Multidisciplinary Sciences

Angiotensin II type-1 receptor (AT1R) regulates expansion, differentiation, and functional capacity of antigen-specific CD8+ T cells

Joao Luiz Silva-Filho et al.

SCIENTIFIC REPORTS (2016)

Add to Collection
Article Public, Environmental & Occupational Health

The Comparative Efficacy and Safety of the Angiotensin Receptor Blockers in the Management of Hypertension and Other Cardiovascular Diseases

Hazel Mae A. Abraham et al.

DRUG SAFETY (2015)

Add to Collection
Editorial Material Cardiac & Cardiovascular Systems

Angiotensin II, From Vasoconstrictor to Growth Factor A Paradigm Shift

Sasa Vukelic et al.

CIRCULATION RESEARCH (2014)

Add to Collection
Review Urology & Nephrology

Alamandine: a new member of the angiotensin family

Daniel C. Villela et al.

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2014)

Add to Collection
Review Multidisciplinary Sciences

A Possible Change Process of Inflammatory Cytokines in the Prolonged Chronic Stress and Its Ultimate Implications for Health

Rui Tian et al.

SCIENTIFIC WORLD JOURNAL (2014)

Add to Collection
Article Physiology

Angiotensin II-induced endothelial dysfunction is temporally linked with increases in interleukin-6 and vascular macrophage accumulation

Jessica R. Gomolak et al.

FRONTIERS IN PHYSIOLOGY (2014)

Add to Collection
Article Nutrition & Dietetics

Boerhaavia diffusa L. attenuates angiotensin II-induced hypertrophy in H9c2 cardiac myoblast cells via modulating oxidative stress and down-regulating NF-κβ and transforming growth factor β1

A. Prathapan et al.

BRITISH JOURNAL OF NUTRITION (2013)

Add to Collection
Article Cardiac & Cardiovascular Systems

Discovery and Characterization of Alamandine A Novel Component of the Renin-Angiotensin System

Roberto Queiroga Lautner et al.

CIRCULATION RESEARCH (2013)

Add to Collection
Article Chemistry, Medicinal

Rational design, efficient syntheses and biological evaluation of N,N′-symmetrically bis-substituted butylimidazole analogs as a new class of potent Angiotensin II receptor blockers

George Agelis et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)

Add to Collection
Article Peripheral Vascular Disease

Effects of telmisartan therapy on interleukin-6 and tumor necrosis factor-alpha levels: a meta-analysis of randomized controlled trials

Hisato Takagi et al.

HYPERTENSION RESEARCH (2013)

Add to Collection
Article Medicine, General & Internal

Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy

Linda F. Fried et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Add to Collection
Review Pharmacology & Pharmacy

A Systematic Comparison of the Properties of Clinically Used Angiotensin II Type 1 Receptor Antagonists

Martin C. Michel et al.

PHARMACOLOGICAL REVIEWS (2013)

Add to Collection
Article Cardiac & Cardiovascular Systems

Inflammatory Cytokines in Heart Failure: Mediators and Markers

Lars Gullestad et al.

CARDIOLOGY (2012)

Add to Collection
Article Biochemistry & Molecular Biology

Interferon-γ biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells

Ryousuke Satou et al.

FASEB JOURNAL (2012)

Add to Collection
Article Cell Biology

Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway

Alia Shatanawi et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2011)

Add to Collection
Review Pharmacology & Pharmacy

Angiotensin II receptors and drug discovery in cardiovascular disease

Chiranjib Dasgupta et al.

DRUG DISCOVERY TODAY (2011)

Add to Collection
Review Peripheral Vascular Disease

Angiotensin Receptor Blockers: Pharmacology, Efficacy, and Safety

Addison A. Taylor et al.

JOURNAL OF CLINICAL HYPERTENSION (2011)

Add to Collection
Article Biochemistry & Molecular Biology

Role of Angiotensin II Type 1 Receptor in Angiotensin II-Induced Cytokine Production in Macrophages

Feng Guo et al.

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2011)

Add to Collection
Article Biochemistry & Molecular Biology

Angiotensin IV protects against angiotensin II-induced cardiac injury via AT4 receptor

Hui Yang et al.

PEPTIDES (2011)

Add to Collection
Review Peripheral Vascular Disease

A current evaluation of the safety of angiotensin receptor blockers and direct renin inhibitors

Helmy M. Siragy

VASCULAR HEALTH AND RISK MANAGEMENT (2011)

Add to Collection
Article Cardiac & Cardiovascular Systems

Circulating Rather Than Cardiac Angiotensin-(1-7) Stimulates Cardioprotection After Myocardial Infarction

Yong Wang et al.

CIRCULATION-HEART FAILURE (2010)

Add to Collection
Review Medicine, Research & Experimental

Regulation in chronic obstructive pulmonary disease: the role of regulatory T-cells and Th17 cells

Nina Lane et al.

CLINICAL SCIENCE (2010)

Add to Collection
Article Pharmacology & Pharmacy

Triple Therapy With Olmesartan Medoxomil, Amlodipine Besylate, and Hydrochlorothiazide in Adult Patients With Hypertension: The TRINITY Multicenter, Randomized, Double-Blind, 12-Week, Parallel-Group Study

Suzanne Oparil et al.

CLINICAL THERAPEUTICS (2010)

Add to Collection
Review Immunology

The Role of the Transcription Factor CREB in Immune Function

Andy Y. Wen et al.

JOURNAL OF IMMUNOLOGY (2010)

Add to Collection
Review Pharmacology & Pharmacy

Trilogy of ACE2: A peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters

Keiji Kuba et al.

PHARMACOLOGY & THERAPEUTICS (2010)

Add to Collection
Article Cell Biology

Anti-Inflammatory Effects of Angiotensin Receptor Blockers in the Brain and the Periphery

Julius Benicky et al.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2009)

Add to Collection
Article Immunology

Heterogeneity of CD4+ memory T cells: Functional modules for tailored immunity

Federica Sallusto et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2009)

Add to Collection
Article Urology & Nephrology

IL-6 and Serum Amyloid A Synergy Mediates Angiotensin II-Induced Muscle Wasting

Liping Zhang et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)

Add to Collection
Article Multidisciplinary Sciences

Losartan Decreases p42/44 MAPK Signaling and Preserves LZ+MYPT1 Expression

Erhan Ararat et al.

PLOS ONE (2009)

Add to Collection
Review Pharmacology & Pharmacy

Cardiac fibroblasts: At the heart of myocardial remodeling

Karen E. Porter et al.

PHARMACOLOGY & THERAPEUTICS (2009)

Add to Collection
Article Pathology

Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway

Vijay Koka et al.

AMERICAN JOURNAL OF PATHOLOGY (2008)

Add to Collection
Article Transplantation

Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy

Minoru Satoh et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)

Add to Collection
Article Medicine, General & Internal

Telmisartan, ramipril, or both in patients at high risk for vascular events

Salim Yusuf et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Add to Collection
Article Ophthalmology

Pro-inflammatory cytokines increase reactive oxygen species through mitochondria and NADPH oxidase in cultured RPE cells

Dongli Yang et al.

EXPERIMENTAL EYE RESEARCH (2007)

Add to Collection
Review Cardiac & Cardiovascular Systems

The regulation of the inflammatory response through nuclear factor-kappa B pathway by angiotensin IV extends the role of the renin angiotensin system in cardiovascular diseases

Marta Ruiz-Ortega et al.

TRENDS IN CARDIOVASCULAR MEDICINE (2007)

Add to Collection
Review Biochemistry & Molecular Biology

Oxidative stress and growth-regulating intracellular signaling pathways in cardiac myocytes

Peter H. Sugden et al.

ANTIOXIDANTS & REDOX SIGNALING (2006)

Add to Collection
Review Pharmacology & Pharmacy

Angiotensin-converting enzyme 2 in lung diseases

Keiji Kuba et al.

CURRENT OPINION IN PHARMACOLOGY (2006)

Add to Collection
Article Biochemistry & Molecular Biology

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury

K Kuba et al.

NATURE MEDICINE (2005)

Add to Collection
Article Multidisciplinary Sciences

Angiotensin-converting enzyme 2 protects from severe acute lung failure

Y Imai et al.

NATURE (2005)

Add to Collection
Article Physiology

Angiotensin II Ca2+ signaling in rat afferent arterioles:: stimulation of cyclic ADP ribose and IP3 pathways

SK Fellner et al.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)

Add to Collection
Article Cardiac & Cardiovascular Systems

Myocardial infarction increases ACE2 expression in rat and humans

LM Burrell et al.

EUROPEAN HEART JOURNAL (2005)

Add to Collection
Article Peripheral Vascular Disease

Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors

Y Ishiyama et al.

HYPERTENSION (2004)

Add to Collection
Article Peripheral Vascular Disease

Angiotensin II regulation of collagen type I expression in cardiac fibroblasts -: Modulation by PPAR-γ ligand pioglitazone

K Chen et al.

HYPERTENSION (2004)

Add to Collection
Article Pharmacology & Pharmacy

p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 1. p38 MAPK-dependent endothelial dysfunction and hypertension

HS Ju et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)

Add to Collection
Article Multidisciplinary Sciences

Independent β-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2

HJ Wei et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Add to Collection
Article Cardiac & Cardiovascular Systems

Involvement of nuclear factor-κB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy

S Hirotani et al.

CIRCULATION (2002)

Add to Collection
Article Peripheral Vascular Disease

Role of the renin-angiotensin system in vascular diseases -: Expanding the field

M Ruiz-Ortega et al.

HYPERTENSION (2001)

Add to Collection
Article Pharmacology & Pharmacy

Effects of angiotensin IV and angiotensin-(1-7) on basal and angiotensin II-stimulated cytosolic Ca2+ in mesangial cells

D Chansel et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2001)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.